Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $22.92 +3.71%
Revenue Growth %: +11.7%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
UBAB, LOAN, FITB, More
Revenue Growth %: +11.7%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $58.88 million versus the consensus estimate of $49.4 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
- Energy Vault Holdings (NRGV) files $300M mixed shelf
- DBV Technologies refreshes ATM program with $150M ADS offering
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
